Literature DB >> 23744893

PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

Leah Rider1, Peter Oladimeji, Maria Diakonova.   

Abstract

p21-Activated serine-threonine kinase (PAK1) is implicated in breast cancer. We have shown previously that PAK1 is tyrosyl phosphorylated by prolactin (PRL)-activated Janus tyrosine kinase (JAK2). Although a role for both PRL and PAK1 in breast cancer is widely acknowledged, the mechanism remains poorly understood. In the present study, PRL-activated PAK1 stimulates the invasion of TMX2-28 human breast cancer cells through Matrigel. Three-dimensional (3D) collagen IV stimulates the secretion of the matrix proteases, metalloproteinase (MMP)-1 and -3 that is further enhanced by the PRL-dependent tyrosyl phosphorylation of PAK1. 3D collagen IV also stimulates the expression and secretion of MMP-2, but in contrast to MMP-1 and -3, PRL/PAK1 signaling down-regulates MMP-2 expression and secretion. In contrast, MMP-9 expression and secretion are stimulated by 3D collagen I, not collagen IV, and are not affected by PRL but are down-regulated by PAK1. MMP-1 and -3 are required and MMP-2 contributes to PRL-dependent invasion. ERK1/2 signaling appears to be required for the enhanced expression and secretion of MMP-1 and -3 and enhanced PRL-dependent invasion. p38 MAPK and c-Jun N-terminal kinase 1/2 pathways participate in production of MMP-1 and -3 as well as in PRL/PAK1-dependent cell invasion. Together, these data illustrate the complex interaction between the substratum and PRL/PAK1 signaling in human breast cancer cells and suggest a pivotal role for PRL-dependent PAK1 tyrosyl phosphorylation in MMP secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744893      PMCID: PMC3706840          DOI: 10.1210/me.2012-1322

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  77 in total

1.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

Authors:  Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

2.  Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.

Authors:  Pedro Cortes-Reynosa; Teresa Robledo; Marina Macias-Silva; S Vincent Wu; Eduardo Perez Salazar
Journal:  Matrix Biol       Date:  2007-11-12       Impact factor: 11.583

Review 3.  Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways.

Authors:  Grégory Giannone; Michael P Sheetz
Journal:  Trends Cell Biol       Date:  2006-03-10       Impact factor: 20.808

4.  Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.

Authors:  M Balduyck; F Zerimech; V Gouyer; R Lemaire; B Hemon; G Grard; C Thiebaut; V Lemaire; E Dacquembronne; T Duhem; A Lebrun; M J Dejonghe; G Huet
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Molecular architecture and function of matrix adhesions.

Authors:  Benjamin Geiger; Kenneth M Yamada
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

6.  Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions.

Authors:  Zhibo Yang; Suresh Rayala; Diep Nguyen; Ratna K Vadlamudi; Shiuan Chen; Rakesh Kumar
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

Review 7.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

8.  Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Authors:  Anwar B Beshir; Gang Ren; Anniefer N Magpusao; Lauren M Barone; Kam C Yeung; Gabriel Fenteany
Journal:  Cancer Lett       Date:  2010-09-19       Impact factor: 8.679

9.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19

10.  Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B.

Authors:  M Bond; R P Fabunmi; A H Baker; A C Newby
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

View more
  25 in total

1.  Src tyrosyl phosphorylates cortactin in response to prolactin.

Authors:  Alan Hammer; Sneha Laghate; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

2.  Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.

Authors:  Maryam Farzaneh Behelgardi; Saber Zahri; Zahra Gholami Shahvir; Farhad Mashayekhi; Laleh Mirzanejad; S Mohsen Asghari
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

3.  Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.

Authors:  Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2015-05-12

Review 4.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

5.  P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.

Authors:  Ahmad Al-Azayzih; Fei Gao; Payaningal R Somanath
Journal:  Biochim Biophys Acta       Date:  2015-03-06

6.  Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.

Authors:  Patricia Bortman Rozenchan; Fatima Solange Pasini; Rosimeire A Roela; Maria Lúcia Hirata Katayama; Fiorita Gonzáles Lopes Mundim; Helena Brentani; Eduardo C Lyra; Maria Mitzi Brentani
Journal:  Tumour Biol       Date:  2015-07-05

7.  Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Authors:  Elena Pedraz-Cuesta; Jacob Fredsted; Helene H Jensen; Annika Bornebusch; Lene N Nejsum; Birthe B Kragelund; Stine F Pedersen
Journal:  Mol Endocrinol       Date:  2016-05-13

8.  Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.

Authors:  Peter Oladimeji; Rebekah Skerl; Courtney Rusch; Maria Diakonova
Journal:  Cancer Res       Date:  2016-03-04       Impact factor: 12.701

9.  Selective Adhesive Cell Capture without Molecular Specificity: New Surfaces Exploiting Nanoscopic Polycationic Features as Discrete Adhesive Units.

Authors:  S Kalasin; E P Browne; K F Arcaro; M M Santore
Journal:  RSC Adv       Date:  2017-02-28       Impact factor: 3.361

10.  PAK1 translocates into nucleus in response to prolactin but not to estrogen.

Authors:  Peter Oladimeji; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2016-03-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.